Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 1c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.52), $0.01 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $844 thousand versus the consensus estimate of $870 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Hermès can regain momentum despite China weakness, Jefferies says